vimarsana.com
  • Home
  • Live Updates
  • Infection-Focused Barinthus Bios VTP-200 Data Underwhelming: Analyst Weighs On Mixed Perspectives : comparemela.com

    • Infection-Focused Barinthus Bio's VTP-200 Data Underwhelming: Analyst Weighs On Mixed Perspectives

    On Friday, Barinthus Biotherapeutics plc (NASDAQ:BRNS), formerly Vaccitech plc, released topline final data from the APOLLO trial (...

    Related Keywords

    Nadege Pelletier , William Blair , Barinthus Biotherapeutics , Barinthus Bio , Nasdaq , Bill Enright , Chief Scientific Officer ,

    © 2024 Vimarsana

    comparemela.com © 2020. All Rights Reserved.